J&J touts PhII da­ta in rare blood dis­or­der as it plots a piv­otal study

Of the moth­ers on J&J’s can­di­date for a rare blood dis­or­der that oc­curs dur­ing preg­nan­cy, more than half achieved a live birth with no in­trauter­ine …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland